DSN senior editor Mike Johnsen examines in depth sales activity in the OTC allergy relief category, with extensive charts and analysis of which brands are driving the growth, how climate change is creating major spikes in the business and more, in this multi-page report.
The DSN PoweRx list represents nearly 80% of the total retail pharmacy business — including more than $250 billion in pharmacy sales and nearly 59,000 pharmacies. And with the rise of more consumer-centered health care, they are creating innovative programs and entering healthcare partnerships to move beyond dispensing and expand their role in the U.S. healthcare delivery system. Read more
Industry leaders talk soulful brands, doing good and operating with purpose at the third annual New General Market Summit. In this special report, DSN highlights the big ideas and best practices that emerged from the event.